The University of Maryland, Baltimore is a public university in Baltimore, Maryland. Founded in 1807, it comprises some of the oldest professional schools of dentistry, law, medicine, pharmacy, social work and nursing in the United States.

During the past decade, University of Maryland conducted 275 clinical trials. In the 10-year time frame, 275 clinical trials started and 161 clinical trials were completed, i.e. on average, 58.5% percent of trials that started reached the finish line to date. In the past 5 years, 128 clinical trials started and 86 clinical trials were completed. i.e. 67.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Maryland" #1 sponsor was "University of Maryland, Baltimore" with 99 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 33 trials sponsored, "University of North Carolina, Chapel Hill" with 17 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 10 trials sponsored and "Actelion" with 10 trials sponsored. Other sponsors include 410 different institutions and companies that sponsored additional 258 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Maryland" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 45 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 26 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 22 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 19 trials as a collaborator and "University of Maryland" with 15 trials as a collaborator. Other collaborators include 460 different institutions and companies that were collaborators in the rest 251 trials.

According to Clinical.Site data, the most researched conditions in "University of Maryland" are "HIV Infections" (16 trials), "Heart Failure" (15 trials), "Influenza" (15 trials), "Schizophrenia" (12 trials) and "Pulmonary Arterial Hypertension" (11 trials). Many other conditions were trialed in "University of Maryland" in a lesser frequency.

Most popular intervention types in "University of Maryland" are "Drug" (278 trials), "Device" (97 trials), "Other" (82 trials), "Biological" (64 trials) and "Behavioral" (40 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (78 trials), "placebo" (7 trials), "Dexamethasone" (5 trials), "Pembrolizumab" (5 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "University of Maryland" are 538 trials for "All" genders, 25 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "University of Maryland". undefined are not yet recruiting, 97 are recruiting, 46 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 323 completed trials in University of Maryland, 4 suspended trials, and 79 terminated clinical trials to date.

Out of the total trials that were conducted in University of Maryland, 56 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 116 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 39 trials, and there were also 137 trials that are defined as “Not Applicable".

University of Maryland has several departments that took part in Clinical trials: "University of Maryland, School of Dentistry" - 14 trials, "University of Maryland, School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry" - 2 trials, "University of Maryland, School of Dentistry, Brotman Facial Pain Clinic" - 2 trials, "University of Maryland Amish Research Clinic" - 2 trials, "Advanced General Dentistry at UMB DS" - 2 trials, "Department of Neurology" - 2 trials, "Luana Colloca" - 2 trials